Read the full article at Deal Street Asia here. By Claire Milhench | 22 February 2018 A record $49 billion was invested in emerging market private equity deals in 2017, data from industry body EMPEA showed on Wednesday, with Asian private capital fundraising at its highest since 2008. With… Read More
LONDON, Feb 21, 2018 (Reuters) – A record $49 billion was invested in emerging market private equity deals in 2017, data from industry body EMPEA showed on Wednesday, with Asian private capital fundraising at its highest since 2008. With investors keen to put money to work in fast-growing… Read More
EMPEA’s just released Year-End 2017 Industry Statistics reveal year-onyear gains in funds raised and capital invested for private capital in emerging markets (“EM”). Public market exits for private capital-backed EM companies also increased as fund managers (“GPs”) took advantage of attractive conditions on public exchanges to list companies and conduct… Read More
Washington, D.C., 22 November 2017 — EMPEA announces today that it has appointed Torbjorn Caesar, Senior Partner of Actis, and Andrew Kuper, Founder and CEO of LeapFrog Investments, to serve on the Board of Directors. Their appointments follow Drew Guff, Managing Director and Founding Partner of Siguler Guff & Company,… Read More
Read the full article at PEI here. (login required) By Carmela Mendoza | 15 November 2017 China fundraising figures from EMPEA show more capital has been raised in renminbi in the first three quarters of 2017, compared with the same period for the previous five years. A total of… Read More
Read the full article at Bloomberg here. By Michelle Jamrisko | 1 November 2017 Southeast Asia is on track to receive less than half the private capital it lured from fund managers in 2016. Investment across the region’s economies slowed to just $896 million in the first half of… Read More
By Claire Milhench | 6 October 2017 Imagine contact lenses that monitor glucose levels for diabetics, tiny implants to tackle chronic diseases, or algorithms that crunch data to predict illness rates. Rather than science fiction, these are examples of cutting-edge research being pioneered by biotech firms seeking to revolutionize healthcare… Read More
Read the full article in The Wall Street Journal here. By Emily Nonko | 3 October 2017 Last year Actis, a London-based investor with a focus on emerging markets, closed its Africa Real Estate Fund with more than $500 million, surpassing its $400 million target. But then the real… Read More
Read the full article at Global Finance here. By Jonathan Gregson | 28 September 2017 Emerging markets have returned to favor with investors, with a pickup in spending by private equity-style funds during the first half of 2017. According to new figures from the Emerging Markets Private Equity Association,… Read More
By Andrew Pitts | 25 September 2017 Follow the money: it’s a phrase that applies not only to investigative pursuits but also to investing. So is the ‘smart money’ suggesting that private investors should be tilting their portfolios towards emerging markets? Last month I suggested that on relative valuation grounds,… Read More
(default archive template)